ADHD and Substance Misuse(Virtual)
This meeting has been organised by CliniLink Ltd and is supported by pharmaceutical companies through sponsorship. The sponsors were not involved in the development of the agenda and have had no influence over the agenda, the speakers or the content of the meeting. Further information about the event and sponsorship can be found below
See Sponsors below
£0.00
WEBINAR
THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY
Location: MS Team
Event Agenda
| Time | Topic | Speaker |
|---|---|---|
| 19:00-19:05 | Introduction | CliniLink |
| 19:05-19:20 | Sponsor Symposium | TBC |
| 19:20-20:20 | ADHD and Substance Misuse Why substance misuse is more common in ADHD, how to assess and screen for it, and the practical prescribing decisions that follow — including stimulant risk, diversion and safer treatment choices. | Dr Ismail Memon |
| 20:20-20:55 | Q&A | Dr Ismail Memon & CliniLink |
| 20:55-21:00 | Close |
Webinar summary
ADHD prescribing is increasingly landing in primary care, whether through shared care agreements, medication queries, or patients waiting on specialist review. This session covers what clinicians need to manage ADHD confidently and safely: the pharmacological and non-pharmacological options, how the main medication categories differ, and the practical prescribing and monitoring points that matter day to day.
Dr Ismail Memon also covers two areas that regularly catch teams out - managing ADHD alongside common comorbidities, and the DVLA implications for patients on treatment.
Learning Outcomes
By the end of this webinar, participants will be able to:
- Understand the pharmacological and non-pharmacological management of ADHD
- Describe the different categories of medication used to treat ADHD symptoms
- Apply practical points about safe prescribing of ADHD medicines
- Recognise and manage ADHD alongside common comorbidities
- Understand the implications of ADHD and its treatment for driving
Key Benefits
- Practical, case-based learning.
- Evidence-based guidance aligned with current UK practice.
- Improve confidence in recognising and managing ADHD.
- Opportunity to ask questions during the live Q&A session.
- CPD-accredited with a certificate of attendance.
Additional Information
- Suitable for GPs, prescribing pharmacists, nurses, physician associates, and other primary care healthcare professionals.
- Free to attend, but advance registration is required.
Meet the Speaker
Dr Ismail Memon
MRCPsych/IFAPA/FEBP/FHEA/AFFMLM/MAcadMEd/MIoLDr Ismail Memon is a General Adult and Perinatal Psychiatrist with specialist expertise in Addiction Psychiatry, ADHD, and Autism. He works within the Perinatal Mental Health Service at Swansea Bay University Health Board, Wales, and also provides private psychiatric care at Eleos Clinic, Harley Street, London.
He is the Exchange Programme Recruitment Lead for the World Psychiatric Association (WPA) Early Career Psychiatrists Section and holds fellowships with the American Psychiatric Association, European Board of Psychiatry, Higher Education Academy (UK), and the Faculty of Medical Leadership and Management (UK). He is also a Member of the Academy of Medical Educators (UK).
Dr Memon is an MRCPsych Examiner, a Member of the Executive Committee of the Academic Faculty of the Royal College of Psychiatrists, and an Elected Member of the Executive Committee of the Devolved Council of the Royal College of Psychiatrists. He has previously served as an Honorary Clinical Tutor at Cardiff University School of Medicine and as an Honorary International Visiting Faculty Member in Pakistan.
His clinical and academic interests include perinatal mental health, ADHD, autism, addiction psychiatry, and medical education.